Malnutrition in neuromuscular diseases in adults and children;Denutrition et affections neuromusculaires de l'adulte et de l'adolescent

Nutrition Clinique et Metabolisme

Volumn 12, Issue 4, 1998, Pages 289-295

  Varille, Venance ^a   Paulus, Jacques ^b   Robert, Dominique ^c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Association Française Contre la Myopathie   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

Body composition; Deglutition disorder; Energy metabolism; False passage; Gastrostomy

Indexed keywords

ARTICLE; COMORBIDITY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENTERIC FEEDING; FOOD INTAKE; GASTROSTOMY; HUMAN; MALNUTRITION; NEUROMUSCULAR DISEASE; PROTEIN DEPLETION;

EID: 0032408595     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0985-0562(98)80033-2     Document Type: Article

References (34)

1. Brooke MH, Fenichel GM, Griggs RC et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 1989; 39: 475-81.
2. Griffiths RD, Edwards RHT. A new chart for weight control in Duchenne muscular dystrophy. Arch Dis Child 1988; 63: 1256-8.
3. Willig TN, Varille V, Navarro J. Analyse de l'état nutritionnel dans les maladies neuromusculaires de l'enfant et conséquences pratiques. In: Journées parisiennes de Pédiatrie. Paris: Flammarion Médecine-Science, 1993: 107-15.
4. Willig TN, Bach R, Varille V, Navarro J. Nutritional rehabilitation in neuromuscular disorders. Seminars in neurology 1995; 15: 18-23.
5. Stevenson RD. Measurement of growth in children with developmental disabilities. Dev Med Child Neurol 1996; 38: 855-60.
6. Frisancho AR. The norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34: 2540-5.
7. Rolland-Cachera MF. Body composition during adolescence: methods, limitations and determinants. Horm Res 1993: 39 (4 suppl): 25-30.
8. Marinier E, Willig TN, Leroy-Willig A. L'impédancemétrie est-elle utilisable chez des patients atteints de myopathie de Duchenne (DMD) pour mesurer la composition corporelle? Corrélation avec la résonance magnétique. Nutr Clin Métabol 1994; 8 (4 suppl): 17.
9. Leroy-Willig A, Willig TN, Henry-Feugeas MC et al. Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy and normal subjects. Magn Reson Imaging 1997; 15: 737-44.
10. Griggs RC, Forbes G, Mowley RT. The assessment of muscle mass in progressive neuromuscular disease. Neurology 1983; 33: 158-65.
11. 2H labeled water. Am J Clin Nutr 1980; 33: 2686-93.
12. Varille V, Barois A. Energy expenditure and body composition of children with inherited neuromuscular diseases. J Pediatr Gastroenterol Nutr 1997; 25 (suppl): 47.
13. Kanda F, Fujii Y, Takahashi K, Fujita T. Dual energy x-ray absorptiometry in neuromuscular diseases. Muscle Nerve 1994; 17: 431-5.
14. Feinberg M, Favier JC, Ireland-Rippert J. Répertoire general des aliments et table de composition. Paris: Technique et documentation Lavoisier, 1991.
15. Varille V, Navarro J. Mesure de la dépense energétique en pédiatrie. Med Nutr 1997; 2: 77-82.
16. Mc Crory MA, Kim HR, Wright NC et al. Energy expenditure, physical activity and body composition of ambulatory adults with hereditary neuromuscular disease. Am J Clin Nutr 1998; 67: 1162-9.
17. Grande F. Energy Expenditure of organs and tissues. In: USA: Kinney J, ed. Assessment of energy metabolism in health and disease. Report of the first Ross conference on Medical Research 1880; 88-92.
18. Gottrand F, Varille V. Aspect nutritionnel des maladies neuromusculaires. In: Leverve X, Cosnes J, Erny P, Hasselman M, Eds. Traité de nutrition artificielle de l'adulte. Paris: Guéna M, ed., 1998: 871-80.
19. Okada K, Manabe S, Sakamoto S, Ohnaka M, Niiyama Y. Protein and energy metabolism in patients with progressive muscular dystrophy. J Nutr Sci Vitaminol 1992; 38: 141-54.
20. 31P-NMR: controlled trials show no effect of allopurinol or ribose. Muscle Nerve 1985; 8: 760-7.
21. Buzby G, Matthews D, Hubbs C, Rosato E. Prognostic nutritional index in gastroenterologic surgery. Am J Surg 1980; 139: 160-7.
22. Legrand-Persoz M, Persoz B, Boulvert E. Surveillance de l'évolution musculaire et respiratoire dans la myopathie de Duchenne de Boulogne à évolution rapide, application au contrôle thérapeutique. Ann Méd Phys 1979; 22: 1-12.
23. Black LF, Hyatt RE. Maximal static respiratory pressure in generalized neuromuscular disease. Am Rev Respir Dis 1971; 103: 641-50.
24. Mercier J, Bennani F, Ferri J, Piot B. Manifestations maxillo-faciales de la dystrophie myotonique de Steinert. Rev Stomatol Chir maxillofac 1995; 2: 74-82.
25. Willig TN, Paulus J, Lacau Saint Guily J, Beon C, Navarro J. Swallowing problems in neuromuscular disorders. Arch Phys Med Rehabil 1994; 75: 1175-81.
26. Willig TN. Tous à table : cuisine adaptée aux difficultés d'alimentation. Paris: APF, 1996.
27. St-Guily JL, Périé S, Willig TN et al. Swallowing disorders in muscular diseases: functional assessment and indications of cricopharyngeal myotomy. Ear Nose Throat J 1994; 73: 34-40.
28. Rozier A, Ruscone-Fourestraux A, Rosenbaum A et al. Place de la gastrostomie endoscopique percutanée dans la sclérose latérale amyotrophique. Rev Neurol 1991; 147: 174-6.
29. Barohn RJ, Levine EJ, Olson JO, Mendell JR. Gastric hypomobility in Duchenne's muscular dystrophy. N Engl J Med 1988; 319: 15-8.
30. Staiano AM, Guidice ED, Romano A et al. Upper gastrointestinal tract motility in children with progressive muscular dystrophy. J Pediatr 1992; 121: 720-4.
31. Bach JR., Zhitinikov S. The management of neuromuscular ventilatory failure. Semin Pediatr Neurol 1998; 5: 92-105.
32. Harpey JP, Charpentier C, Paturneau-Jouas M. Secondary metabolic defects in spinal muscular atrophy type II. Lancet 1990; 336: 629-30.
33. Tiomny E, Khilkevic O, Korczyn AD et al. Esophageal smooth muscle dysfunction in oculopharyngeal muscular dystrophy. Dig Disease Sci 1996; 41: 1350-54.
34. Horowitz A, Maddox A, Maddern GJ et al. Gastric and esophageal emptying in dystrophia myotonica: effect of metoclopramide. Gastroenterology 1987; 92: 570-7.